Compare Recursion Pharmaceuticals Inc (RXRX) vs US Bancorp (USB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs US Bancorp — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while US Bancorp trades at $63.14 (market cap $98.36B). The key difference: US Bancorp is far larger — about 64.3× Recursion Pharmaceuticals Inc's market cap, and US Bancorp pays a 3.29% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | USB | |
|---|---|---|
Market Cap | $1.53B | $98.36B |
Sector | Health | Financials |
52-Week High | $6.79 | $64.01 |
52-Week Low | $2.84 | $43.94 |
Enterprise Value | $946.50M | — |
Dividend Yield | — | 3.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
